ClinicalTrials.Veeva

Menu

Evaluating of New Screening Tool for Arthritis* in Psoriasis (TUPAST)

B

Bezmialem Vakif University

Status

Completed

Conditions

Psoriasis
Psoriatic Arthritis

Treatments

Diagnostic Test: Questionary

Study type

Observational

Funder types

Other

Identifiers

NCT04277832
54022451-050.05.05

Details and patient eligibility

About

This study evaluates a new screening tool for arthritis in psoriasis and compares its reliability with well-known screening tool (TOPAS 2).

Full description

Early diagnosis and treatment of PsA may prevent destruction in joints.Our aim is to create a simple and user friendly screening tool that can be used by dermatologists in out patient clinics.

A question pool will be created from a review of the literature and expert opinions from a physicians experienced in rheumatology and dermatologists .Psoriasis patients will answer these newly created questions. All patients will be examined by dermatology and also physical therapy and rehabilitation-rheumatology experts. The diagnosis of psoriatic arthritis (PsA) will be made by CASPAR (Classification criteria for psoriatic arthritis) criteria and ASAS (Assessment of Spondyloarthritis International Society) criteria for spondyloarthritis. Synchronously patients will be asked for to reply Turkish version of well known questionary named TOPAS 2. According to the results of collected data, statistically best matched questions will be selected for Turkish population. Also, the reliability of TUPAST (Turkish PsA Screening Tool) and TOPAS 2 (Toronto Psoriatic Arthritis Screen II) will be compared statistically.

Enrollment

200 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Psoriasis confirmed by dermatologist

Exclusion criteria

  • Unable to consent and understand
  • Known other rheumatological disease

Trial design

200 participants in 1 patient group

single arm
Description:
Group of psoriasis patients will select randomly. All selected psoriasis patients will be consulted to a physician experienced in rheumatology and all of patients will fill TUPAST and TOPAS 2 forms.
Treatment:
Diagnostic Test: Questionary

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems